Royalty Pharma plc (RPRX) has a market capitalization of $20.92B and trades at $48.82. The 52-week range is 29.66-49.06.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 21, Earnings Per Share (EPS) of $2.33, annual revenue of $2.38B.
The stock has a beta of 0.39, a last dividend of $0.8950, operates in the Healthcare sector.
